The Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The base contract, valued at $922,772, provides the VA with an ongoing vehicle to procure influenza A/B and COVID-19 testing supplies and services without socioeconomic set-asides. Under this IDC, the VA has issued multiple firm...
The Department of Veterans Affairs (VA) awarded Roche Diagnostics Corporation, a leading manufacturer of in vitro diagnostics and medical laboratory equipment, an Indefinite Delivery Contract (IDC) valued at $2,821,000.00. The contract covers the provision of ROCHE CONSUMABLES, including diagnostic test kits, reagents, and laboratory instruments, to support medical testing services at VA facilities. Roche Diagnostics holds multiple IDCs and Blanket Purchase Agreements (BPAs) with the VA and...
The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at up to $15,466,932.92, is for the rental of Molecular Diagnostics Analyzers and associated reagents to support the VA's laboratory testing capabilities across its healthcare facilities. Two delivery orders have been issued...
The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, an Indefinite Delivery Contract (IDC) to provide molecular pathology products and services. Under this IDC, the VA has issued multiple firm fixed-price delivery orders to Roche Diagnostics over a 5-year period, with a total ceiling value of $3,000,000. The delivery orders will supply clinical chemistry analyzers, reagents, test...
The federal agency, the Department of Veterans Affairs Veterans Health Administration (VA), awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The IDC has a ceiling value of $667,159.30 and an ultimate completion date of August 31, 2030, for the provision of REAGENTS AND CONSUMABLES. Under this IDC, a $135,281.86...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $415,022.25 contract has a period of performance from September 1, 2024 to August 31, 2027 and is for the provision of Roche Diagnostics' COVID-19 reagents and Cobas supplies to the VA. Roche Diagnostics has been awarded numerous...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA-VHA VISN 17) awarded a single-award Indefinite Delivery Contract (IDC) valued at $1,963,596.60 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide Roche Ventana reagents and consumables. This 5-year IDC serves as a vehicle for the VA to issue fixed-price delivery orders against, as needed, to support pathology and histology services at VA medical...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide laboratory testing supplies and equipment. The IDV has a potential value of $6.5 million and period of performance through June 2027. Three delivery orders have been issued against the contract to date for a total of $246,135.04, $231,704.12, and $13,824 for reagents, supplies, and molecular testing systems...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) valued at $167,300 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical laboratory equipment. The contract, which has a period of performance through June 30, 2030, provides for the delivery of Roche LIAT consumables, including test kits and controls for COVID-19, Influenza A/B, RSV, and Group A Streptococcus testing, to the VA's Veterans...
The Department of Veterans Affairs (VA) awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The contract, valued at up to $2,000,000, covers the delivery of CTX respiratory pathogen testing capabilities to the VA's Veterans Integrated Service Network 17 from July 2023 through June 2028.
Under this IDC, the VA has issued multiple firm-fixed-price delivery orders to Roche Diagnostics, totaling $659,109.36 to date. These orders provide the VA with CTX respiratory pathogen reagents, testing panels, and remote service support for the ePLEX diagnostic platform. Roche Diagnostics, which holds multiple GSA Schedule contracts and IDVs with federal agencies, will deliver these critical laboratory products and services to VA healthcare facilities in Castleton, Indiana. This contract award supports the VA's efforts to maintain essential respiratory pathogen testing capabilities across its medical system.